Simplex Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Simplex Trading’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$744	Buy	+600	New	+$763	﹤0.01%	8663
2025 Q1	–	Sell	-700	Closed	-$1K	–	9393
2024 Q4	$1K	Hold	700	–	–	﹤0.01%	8289
2024 Q3	$1K	Hold	700	–	–	﹤0.01%	8248
2024 Q2	$1K	Sell	700 -100	-13%	-$180	﹤0.01%	8528
2024 Q1	$1K	Sell	800 -8,500	-91%	-$15.9K	﹤0.01%	8621
2023 Q4	$28K	Sell	9,300 -300	-3%	-$794	﹤0.01%	6635
2023 Q3	$58K	Buy	+9,600	New	+$66K	﹤0.01%	5666
2022 Q4	–	Sell	-700	Closed	-$8K	–	10142
2022 Q3	$8K	Sell	700 -9,200	-93%	-$133K	﹤0.01%	8426
2022 Q2	$141K	Buy	9,900 +1,600	+19%	+$23.3K	﹤0.01%	5084
2022 Q1	$172K	Buy	8,300 +8,200	+8,200%	+$145K	﹤0.01%	5371
2021 Q4	$2K	Buy	+100	New	+$2.42K	﹤0.01%	10031

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Simplex Trading's PMVP Position: Q1 2026 in Review

Simplex Trading reduced its PMV Pharmaceuticals (PMVP) stake by 71% in Q1 2026, selling an estimated $25K and leaving 8,181 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7346.

Simplex Trading first reported a position in PMVP in Q4 2021 and has held it in 14 quarters since. The position peaked at $694K in Q2 2022. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

Simplex Trading held 8,181 shares of PMV Pharmaceuticals worth $10.1K as of Q1 2026.
Simplex Trading sold 19,681 PMV Pharmaceuticals shares in Q1 2026, an estimated $25K.
PMV Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7346 holding.
Simplex Trading first reported a position in PMV Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
Simplex Trading's PMV Pharmaceuticals position peaked at $694K in Q2 2022.
69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.